INVO Fertility (IVF) Change in Account Payables (2011 - 2020)

INVO Fertility's (IVF) quarterly Change in Account Payables came in at -$96566.0 in Q4 2020, down 166.44% year-on-year from $145345.0 in Q1 2020, and down 214.31% on a QoQ basis from $84480.0 in Q3 2020.

INVO Fertility (IVF) Change in Account Payables (2011 - 2020) Analysis & Trends

INVO Fertility (IVF) has 3 years of Change in Account Payables data on file, last reported at -$96566.0 in Q4 2020.

  • On a quarterly basis, Change in Account Payables fell 166.44% year-over-year to -$96566.0 in Q4 2020; TTM through Dec 2020 was -$61696.0, a 168.71% decrease from a year earlier, with the FY2020 full-year figure at -$61696.0, down 168.71% from the prior year.
  • Change in Account Payables for Q4 2020 stood at -$96566.0, down from $84480.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for IVF reached as high as $145345.0 in Q4 2019 and fell as low as -$96566.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -198.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 221.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 INVO Fertility 1,108.74 -4.90 Mn 732,978.00 -

Historic Data

Download Data
DateValue
Dec 31, 2020 -96,566.00
Dec 31, 2020 -96,566.00
Sep 30, 2020 84,480.00
Sep 30, 2020 84,480.00
Jun 30, 2020 -59,931.00
Jun 30, 2020 -59,931.00
Mar 31, 2020 10,321.00
Mar 31, 2020 10,321.00
Dec 31, 2019 145,345.00
Dec 31, 2019 145,345.00
Sep 30, 2019 -80,011.00
Sep 30, 2019 -80,011.00
Jun 30, 2019 24,458.00
Jun 30, 2019 24,458.00
Sep 30, 2011 -11,583.00
Sep 30, 2011 -11,583.00